Cyclerion Therapeutics Inc Share Price

NASDAQ: CYCN

Small Cap

$2.42

-0.13

(-5.10%)

as on September 13, 2025 at 1:29 am IST

$₹

Cyclerion Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$2.4
Day's Price Range
$2.55
$2.42
0.83%
Downside
5.37%
Upside
52 Week's Low
52 Week's High
$1.27
52-Week Price Range
$9.47
$2.42
47.52%
Downside
291.32%
Upside

Cyclerion Therapeutics Inc share price movements today

Previous Close: $2.55
Open: $2.55
Volume: 469.1K
Day's Low - High: $2.4 - $2.55
52 Week Low - High: $1.27 - $9.47

Cyclerion Therapeutics Inc Historical Returns

1 Month Return: -0.4 %
3 Month Return: -20.99 %
1 Year Return: -15.17 %
3 Year Return: -87.58 %
5 Year Return: -98.16 %

Cyclerion Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cyclerion Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.9M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.79

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-9.6M

Revenue (TTM)

2.2M

Profit Margin

-89.51%

Return On Equity TTM

0.00%

Cyclerion Therapeutics Inc Stock Valuation

Track how Cyclerion Therapeutics Inc P/E has moved over time to understand its valuation trends.

Cyclerion Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (2.22x)

June 30, 2024

Industry (0.00x)

September 13, 2025

Today (-0.79x)

September 13, 2025

Highest (2.22x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.79x

Cyclerion Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cyclerion Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cyclerion Therapeutics Inc	BUY	$7.9M	-98.16%	-0.79	-89.51%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Cyclerion Therapeutics Inc Stock including INR - Dollar returns

The Cyclerion Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cyclerion Therapeutics Inc investment value today

Current value as on today

₹88,587

Returns

₹11,413

(-11.41%)

Returns from Cyclerion Therapeutics Inc Stock

₹16,552 (-16.55%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Cyclerion Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Cyclerion Therapeutics Inc. Average target price of $4

Cyclerion Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cyclerion Therapeutics Inc.

What analysts predicted

39.5%UPSIDE

Target Price

Current Price

$2.42

Analyzed by

7 Analysts

Target

$4.00

Cyclerion Therapeutics Inc target price $4, a slight upside of 39.5% compared to current price of $2.42. According to 7 analysts rating.

Cyclerion Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Cyclerion Therapeutics Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:-33% versus previous 30 day period

Cyclerion Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	0	1	0	0
Gross Profit	-	-	-	-	-	-	0	1	0	-
Operating Income	-7	-4	-6	-1	-1	-1	-1	0	-1	-1
EBITDA	-7	-4	-2	-1	-1	-1	-1	0	-1	-1
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-4	-5	-1	-1	-1	0	0	-1	0
Income Tax Expense	0	0	-16	17	0	-	-	-	-	-
Net Income	-6	-4	7	-1	-1	-1	0	0	-1	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-372.68%	29.35%	-1764.20%	-348.39%

Cyclerion Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	4	2	3	0	-	2
Gross Profit	-2	-1	-1	4	2	2	0	-	2
Operating Income	-63	-93	-115	-125	-81	-55	-44	-9	-3
EBITDA	-61	-92	-113	-122	-81	-55	-18	-12	-3
Interest Expense	-	-	-	-	0	0	0	-	-
Depreciation	-	1	1	2	2	0	0	-	-
Income Before Tax	-63	-93	-115	-123	-77	-51	-44	-12	-3
Income Tax Expense	-	-	1	-2	-5	0	0	8	-
Net Income	-63	-93	-115	-120	-72	-51	-43	-21	-3
Net Profit Margin	0.00%	0.00%	0.00%	-2684.25%	-3165.07%	-1556.11%	-14742.09%	0.00%	-152.85%

Cyclerion Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	7	-1	-1	-1	0	0	-1	0
Operating Cash Flow	-6	-6	-1	-1	-1	-1	0	0	0
Investing Cash Flow	-	10	-10	-	-	-	-	-	-
Financing Cash Flow	5	-	-	-	-	-	-	1	0
Change in Cash	-1	3	-1	-1	-1	-1	0	0	0

Cyclerion Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-93	-115	-123	-77	-51	-44	-5	-3
Operating Cash Flow	-81	-97	-102	-72	-36	-40	-21	-4
Investing Cash Flow	-1	-3	-6	0	1	-	10	-
Financing Cash Flow	82	100	211	28	30	0	5	-
Change in Cash	102	102	102	-44	-4	-40	-5	-4

Global Institutional Holdings in Cyclerion Therapeutics Inc

Funds	Holdings
TYNDALL CAPITAL PARTNERS L P	4.63%
Tyndall Management, LLC	4.63%
Siren, L.L.C.	3.26%
Geode Capital Management, LLC	0.89%
Vanguard Group Inc	0.66%

See all

Insights on Cyclerion Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 91.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 213.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, CYCN stock has moved down by -87.7%

About Cyclerion Therapeutics Inc

cyclerion therapeutics, inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. its product candidates include olinciguat, an orally administered vascular soluble guanylate cyclase (sgc) stimulator that is in phase ii studies for the treatment of sickle cell disease (scd); praliciguat, an orally administered systemic sgc stimulator that is in phase ii trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction; and iw-6463, an orally administered central nervous system (cns)-penetrant sgc stimulator, which is in phase i trials for neurodegenerative diseases. the company is also discovering liver-targeted sgc and lung-targeted sgc stimulators. cyclerion therapeutics, inc. was incorporated in 2018 and is headquartered in cambridge, massachusetts.

Organisation	Cyclerion Therapeutics Inc
Headquarters	245 First Street, Riverview II, Cambridge, MA, United States, 02142
Industry	Pharmaceuticals: Major
CEO	Dr. Regina M. Graul Ph.D.
E-voting on shares	Click here to vote

Key Management of Cyclerion Therapeutics Inc

Name	Title
Dr. Regina M. Graul Ph.D.	CEO, President & Director
Ms. Rhonda M. Chicko CPA	Chief Financial Officer

FAQs

What is Cyclerion Therapeutics Inc share price today?

Cyclerion Therapeutics Inc share price today is $2.42 as on September 13, 2025 at 1:29 am IST at the close of the market. Cyclerion Therapeutics Inc share today touched a day high of $2.55 and a low of $2.4.

What is the 52 week high and 52 week low for Cyclerion Therapeutics Inc share?

Cyclerion Therapeutics Inc share touched a 52 week high of $9.47 on December 4, 2024 and a 52 week low of $1.27 on November 22, 2024. Cyclerion Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $2.42,which is 74.45% down from its 52 week high and 90.55% up from its 52 week low.

What is Cyclerion Therapeutics Inc's market capitalisation today?

Cyclerion Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Cyclerion Therapeutics Inc Stock (CYCN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cyclerion Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cyclerion Therapeutics Inc Shares that will get you 0.6198 shares as per Cyclerion Therapeutics Inc share price of $2.42 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cyclerion Therapeutics Inc Stock (CYCN) from India?

Indian investors can start investing in Cyclerion Therapeutics Inc (CYCN) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 2:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Cyclerion Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 2:41 am IST). Based on Cyclerion Therapeutics Inc share’s latest price of $2.42 as on September 13, 2025 at 1:29 am IST, you will get 4.1322 shares of Cyclerion Therapeutics Inc. Learn more about fractional shares .

What are the returns that Cyclerion Therapeutics Inc has given to Indian investors in the last 5 years?

Cyclerion Therapeutics Inc stock has given -98.16% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?